摘要
目的探索紫杉醇治疗子宫颈癌与子宫内膜癌的效果。方法选取2015年4月22日—2016年4月22日我院收治的100例子宫颈癌与子宫内膜癌患者,将其抽签化分组,两组各有50例,对照组和观察组分别采用阿奇霉素治疗和紫杉醇治疗。结果观察组患者的总有效率(96.00%)、不良事件发生率(4.00%)、死亡率(0.00%)、复发率(2.00%)均优于对照组(P<0.05)。结论对子宫颈癌与子宫内膜癌患者实施紫杉醇治疗,能够提高远期疗效,降低不良反应发生率。
Objective To explore the effect ofpaclitaxel in the treatment of cervical cancer and endometrial carcinoma. Methods 100 cases of cervical cancer and endometrial cancer patients were selected from April 22, 2015 to April 22, 2016, and were divided into two groups, there were 50 cases in each group, and the control group and the observation group were treated with azithromycin and paclitaxel respectively. Results The total effective rate （96.00%）, the incidence of adverse events （4.00%）, the mortality rate （0.00%） and the recurrence rate （2.00%） were better in the observation group than in the control group （P〈0.05）. Conclusion Paclitaxel treatment of cervical cancer and endometrial cancer patients can improve long-term efficacy and reduce the incidence of adverse reactions.
作者
刘永刚
LIU Yonggang(Department of Gynaecology, Chifeng Hospital, Chifeng lnner Mongolia 024000, Chin)
出处
《中国继续医学教育》
2017年第14期181-182,共2页
China Continuing Medical Education
关键词
紫杉醇
子宫颈癌
子宫内膜癌
paclitaxel
cervical cancer
endometrial cancer
